Ataxia-telangiectasia Mutated (ATM) Gene Mutation in a Patient with Primary Cutaneous Marginal Zone Lymphoma

Overview

Journal JAAD Case Rep

Specialty Dermatology

Date 2022 Apr 21

PMID 35445145

Authors

Melissa M Sarver

Kimberly F Breglio

Elise A Olsen

Affiliations

Soon will be listed here.

References

Onaindia A, Medeiros L, Patel K . Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. Mod Pathol. 2017; 30(10):1338-1366. DOI: 10.1038/modpathol.2017.58. View

Gibson S, Swerdlow S . How I Diagnose Primary Cutaneous Marginal Zone Lymphoma. Am J Clin Pathol. 2020; 154(4):428-449. DOI: 10.1093/ajcp/aqaa116. View

Nihal M, Mikkola D, Horvath N, Gilliam A, Stevens S, Spiro T . Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003; 34(6):617-22. DOI: 10.1016/s0046-8177(03)00075-3. View

Dosani M, Schrader K, Nichol A, Sun S, Shenkier T, Lohn Z . Severe Late Toxicity After Adjuvant Breast Radiotherapy in a Patient with a Germline Ataxia Telangiectasia Mutated Gene: Future Treatment Decisions. Cureus. 2017; 9(7):e1458. PMC: 5593749. DOI: 10.7759/cureus.1458. View

Bogusz A, Bagg A . Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. Leuk Lymphoma. 2016; 57(9):1991-2013. DOI: 10.3109/10428194.2016.1173212. View

Servitje O, Muniesa C, Benavente Y, Monsalvez V, Garcia-Muret M, Gallardo F . Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients. J Am Acad Dermatol. 2013; 69(3):357-65. DOI: 10.1016/j.jaad.2013.04.047. View

Lang C, Ramelyte E, Dummer R . Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma. Front Oncol. 2020; 10:1163. PMC: 7426470. DOI: 10.3389/fonc.2020.01163. View

Edinger J, Kant J, Swerdlow S . Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol. 2010; 34(12):1830-41. DOI: 10.1097/PAS.0b013e3181f72835. View

Dalle S, Thomas L, Balme B, Dumontet C, Thieblemont C . Primary cutaneous marginal zone lymphoma. Crit Rev Oncol Hematol. 2009; 74(3):156-62. DOI: 10.1016/j.critrevonc.2009.09.003. View

10.

Bremer M, Klopper K, Yamini P, Bendix-Waltes R, Dork T, Karstens J . Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother Oncol. 2003; 69(2):155-60. DOI: 10.1016/j.radonc.2003.08.004. View

11.

Choi M, Kipps T, Kurzrock R . ATM Mutations in Cancer: Therapeutic Implications. Mol Cancer Ther. 2016; 15(8):1781-91. DOI: 10.1158/1535-7163.MCT-15-0945. View

12.

Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow S . The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019; 133(16):1703-1714. PMC: 6473500. DOI: 10.1182/blood-2018-11-881268. View

13.

Braggio E, Dogan A, Keats J, Chng W, Huang G, Matthews J . Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012; 25(5):651-60. PMC: 3341516. DOI: 10.1038/modpathol.2011.213. View